These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2147555)
21. The effect of heparin vs. citrate on the interaction of platelets with vascular graft materials. Kottke-Marchant K; Anderson JM; Rabinovitch A; Huskey RA; Herzig R Thromb Haemost; 1985 Dec; 54(4):842-8. PubMed ID: 2935968 [TBL] [Abstract][Full Text] [Related]
22. Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Hanson SR; Kotze HF; Savage B; Harker LA Arteriosclerosis; 1985; 5(6):595-603. PubMed ID: 2934045 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the thrombogenicity of four types of knitted Dacron arterial graft in an artificial circulation. Deacon P; Crow MJ; Rajah SM; Kester RC Biomaterials; 1985 Jan; 6(1):64-7. PubMed ID: 3155974 [TBL] [Abstract][Full Text] [Related]
24. Heparin-bonded grafts induce platelet aggregation in the presence of heparin-associated antiplatelet antibodies. Almeida JI; Liem TK; Silver D J Vasc Surg; 1998 May; 27(5):896-900; discussion 900-1. PubMed ID: 9620142 [TBL] [Abstract][Full Text] [Related]
25. A compliant Corethane/Dacron composite vascular prosthesis. Comparison with 4-mm ePTFE grafts in a canine model. Wilson GJ; MacGregor DC; Klement P; Weber BA; Binnington AG; Pinchuk L ASAIO J; 1993; 39(3):M526-31. PubMed ID: 8268591 [TBL] [Abstract][Full Text] [Related]
26. Platelet interactions with the vessel wall and prosthetic grafts. Rubin BG; Santoro SA; Sicard GA Ann Vasc Surg; 1993 Mar; 7(2):200-7. PubMed ID: 8518140 [TBL] [Abstract][Full Text] [Related]
27. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs. Kester RC Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841 [TBL] [Abstract][Full Text] [Related]
28. Antiplatelet therapy and vascular grafts. Studies in a baboon ex vivo shunt. Eldrup-Jorgensen J; Connolly RJ; Mackey WC; Ramberg K; O'Donnell TF; Valeri CR; Callow AD Arch Surg; 1986 Jul; 121(7):778-81. PubMed ID: 2940991 [TBL] [Abstract][Full Text] [Related]
29. Antithrombotic activity of Bay u3405, a thromboxane A2-antagonist, in patients with Dacron aortic grafts: a random controlled clinical trial. Pieters H; Roodt JP; Badenhorst PN; van Wyk V; Schall R; Lötter MG; Hundt HK; Nel CJ Thromb Haemost; 1993 Dec; 70(6):903-8. PubMed ID: 8165609 [TBL] [Abstract][Full Text] [Related]
30. The antithrombotic nature of vascular prosthetic pseudointima. Clagett GP; Robinowitz M; Maddox Y; Langloss JM; Ramwell PW Surgery; 1982 Jan; 91(1):87-94. PubMed ID: 6459657 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716 [TBL] [Abstract][Full Text] [Related]
33. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts. Valentin LI; Sicard GA; Freeman MB; Allen BT; McGoff MA; Anderson CB Surgery; 1988 Aug; 104(2):178-84. PubMed ID: 3135624 [TBL] [Abstract][Full Text] [Related]
34. The role of an endothelial cell lining in limiting distal anastomotic intimal hyperplasia of 4-mm-I.D. Dacron grafts in a canine model. Graham LM; Brothers TE; Vincent CK; Burkel WE; Stanley JC J Biomed Mater Res; 1991 Apr; 25(4):525-33. PubMed ID: 1711050 [TBL] [Abstract][Full Text] [Related]
35. Effects of a tetrafluoroethylene glow discharge on patency of small diameter dacron vascular grafts. Garfinkle AM; Hoffman AS; Ratner BD; Reynolds LO; Hanson SR Trans Am Soc Artif Intern Organs; 1984; 30():432-9. PubMed ID: 6241970 [No Abstract] [Full Text] [Related]
36. Isotopic study of the effects of platelets on development of intimal thickening in autologous vein grafts in dogs. Yukizane T; Okadome K; Eguchi H; Muto Y; Sugimachi K Br J Surg; 1991 Mar; 78(3):297-302. PubMed ID: 2021842 [TBL] [Abstract][Full Text] [Related]
37. Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts. Scharn DM; Oyen WJ; Klemm PL; Verhofstad AA; van der Vliet JA J Surg Res; 2006 Aug; 134(2):182-9. PubMed ID: 16542682 [TBL] [Abstract][Full Text] [Related]
38. Satigrel, a new antiplatelet agent, inhibits platelet accumulation in prosthetic arterial grafts. Esato K; Kubo Y; Yasuda K; Shigematsu H; Iwai T; Ishimaru S; Uchida H; Ishii K Am J Surg; 1998 Jan; 175(1):56-60. PubMed ID: 9445241 [TBL] [Abstract][Full Text] [Related]
39. Comparative study of the thromboresistance of Dacron combined with various polyurethanes. Leake DL; Cenni E; Cavedagna D; Stea S; Ciapetti G; Pizzoferrato A Biomaterials; 1989 Sep; 10(7):441-4. PubMed ID: 2529915 [TBL] [Abstract][Full Text] [Related]
40. Beneficial effect of aspirin in maintaining the patency of small-caliber prosthetic grafts after thrombolysis with urokinase or tissue-type plasminogen activator. Curl GR; Jakubowski JA; Deykin D; Bush HL Circulation; 1986 Sep; 74(3 Pt 2):I21-4. PubMed ID: 3091289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]